cirrhosis with portal hypertension icd 10
Release time :Nov-08,2024
Cirrhosis accompanied by portal hypertension represents an advanced stage of liver disease, potentially leading to complications such as ascites and esophageal varices. This condition necessitates a multidisciplinary approach from a specialized medical team, with patients requiring ongoing monitoring and treatment plan adjustments.
The objectives of treating cirrhosis with portal hypertension are to alleviate symptoms, prevent complications, and, if possible, improve liver function. Treatment strategies encompass pharmacological therapy, dietary modifications, and, when necessary, surgical interventions. Pharmacological options may include the use of diuretics to facilitate the removal of excess fluid and reduce ascites, as well as beta-blockers to lower portal pressure and decrease the risk of esophageal varices rupture and bleeding. In cases of severe ascites, therapeutic paracentesis may be indicated. Dietary recommendations may involve sodium restriction to minimize fluid retention and, for patients with impaired protein metabolism, protein intake may also need to be limited. If medical and dietary measures fail to manage the condition, procedures such as shunt surgery or liver transplantation may be considered.
Patients with cirrhosis and portal hypertension should prioritize rest, avoid excessive fatigue, and maintain a positive mental state in their daily lives. Compliance with medical advice for regular follow-ups is crucial to enable timely adjustments to the treatment plan. Adherence to prescribed medication regimens is mandatory, and patients must not alter dosages or switch medications without medical guidance. Should any discomfort arise, immediate medical consultation is advised.